Tarveda Therapeutics
Watertown, US · Founded 2011 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
Tarveda Therapeutics was founded in 2011 by Omid Farokhzad and Robert S. Langer, Jr..
OF
Omid FarokhzadCo-founder
RS
Robert S. Langer, Jr.Co-founder
AJ
Andrew J. FromkinExecutive
LA
Leila AllandExecutive
RW
Richard WoosterExecutive
OC
Omid C. FarokhzadNamed on SEC filing
RS
Robert S. LangerNamed on SEC filing
PB
Peter Barton HuttNamed on SEC filing
EM
Edwin M. KaniaNamed on SEC filing
Board
JB
James BarrettBoard director
FT
Frank TortiBoard director
NK
Nilesh KumarBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$103.6M disclosed across 6 rounds · 2014–2021
▶$6MraisedSep 2021 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedSep 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aymeric SallinDirector
- Michael MetzgerDirector
- Brian RobertsExecutive Officer, Director
- Nilesh KumarDirector
- Dennis AusielloDirector
- Guido MagniDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedDec 2020 · 8 investors · BiotechnologyRule 506(b)
▶$15MraisedDec 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nilesh KumarDirector
- Guido MagniDirector
- Michael MetzgerDirector
- Aymeric SallinDirector
- Brian RobertsExecutive Officer
- Dennis AusielloDirector
- Offering amount
- $15.4M
- Amount sold
- $15M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.6MraisedDec 2019 · 13 investors · BiotechnologyRule 506(b)
▶$13.6MraisedDec 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael MetzgerDirector
- Aymeric SallinDirector
- Robert LangerDirector
- Nilesh KumarDirector
- Guido MagniDirector
- Omid FarokhzadDirector
- Andrew J. FromkinExecutive Officer, Director
- Dennis AusielloDirector
- Offering amount
- $13.6M
- Amount sold
- $13.6M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38MraisedFeb 2017 · 8 investors · BiotechnologyRule 506(b)
▶$38MraisedFeb 2017 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aymeric SallinDirector
- Andrew FromkinExecutive Officer, Director
- Robert S. LangerDirector, Promoter
- Leila AllandExecutive Officer
- Edwin M. KaniaDirector
- James BarrettDirector
- Dennis AusielloDirector
- Nilesh KumarDirector
- Richard WoosterExecutive Officer
- Omid C. FarokhzadDirector, Promoter
- Frank TortiDirector
- Offering amount
- $38M
- Amount sold
- $38M
- Finders' fees
- $720K
- Proceeds to insiders
- $2.5M
- Placement agents
- MTS Securities, LLC
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedFeb 2017 · 7 investors · BiotechnologyRule 506(b)
▶$30MraisedFeb 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. FromkinExecutive Officer, Director
- Omid FarokhzadDirector
- James BarrettDirector
- Frank TortiDirector
- Robert S. Langer, Jr.Director
- Leila AllandExecutive Officer
- Nilesh KumarDirector
- Dennis AusielloDirector
- Richard WoosterExecutive Officer
- Aymeric SallinDirector
- Guido MagniDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1000KraisedMar 2014 · 1 investors · BiotechnologyRule 506(b)
▶$1000KraisedMar 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Omid C. FarokhzadDirector
- Robert S. LangerDirector
- James BarrettDirector
- Richard WoosterExecutive Officer
- Peter Barton HuttDirector
- Aymeric SallinDirector
- Edwin M. KaniaDirector
- Offering amount
- $1000K
- Amount sold
- $1000K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Tarveda Therapeutics?
- Tarveda Therapeutics was founded by Omid Farokhzad, Robert S. Langer, Jr. in 2011.
- Who are Tarveda Therapeutics's investors?
- Tarveda Therapeutics's investors include +ND Capital, Kendall Capital Partners.
- How much funding has Tarveda Therapeutics raised?
- Tarveda Therapeutics has disclosed $103.6M raised across 6 rounds.
- Where is Tarveda Therapeutics headquartered?
- Tarveda Therapeutics is headquartered in Watertown, US.